Chest ACCP Member Benefits
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by McFarland, J. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by McFarland, J. G.
(Chest. 1999;115:113S-121S.)
© 1999 American College of Chest Physicians

Perioperative Blood Transfusions*

Indications and Options

Janice G. McFarland, MD

* From the Blood Center of Southeastern Wisconsin, Milwaukee, WI.

Correspondence to: Janice G. McFarland, MD, Vice President, Medical Affairs, The Blood Center of Southeastern Wisconsin, 638 N 18th St, PO Box 2178, Milwaukee, WI 53201-2178

A reevaluation of the indications for and alternatives to transfusion of allogeneic blood was precipitated by transfusion-induced HIV. The transfusion trigger has shifted from an optimal hemoglobin level and hematocrit (10/30) to that level of hemoglobin necessary to meet the patient’s tissue oxygen demands. This critical level can best be determined by physiologic measurements. A number of autologous blood options can reduce the patient’s allogeneic blood needs. Pharmacologic measures to increase hemoglobin levels (erythropoietin) and to decrease blood loss at surgery are discussed as are the potential contributions of blood substitutes to transfusion support of the surgical patient.




This article has been cited by other articles:


Home page
 PerfusionHome page
F. Merkle, W. Boettcher, F. Schulz, A. Koster, M. Huebler, and R. Hetzer
Perfusion technique for nonhaemic cardiopulmonary bypass prime in neonates and infants under 6 kg body weight
Perfusion, July 1, 2004; 19(4): 229 - 237.
[Abstract] [PDF]

Home page
 Annals of Clinical & Laboratory ScienceHome page
S. M. Hopfer, F. L. Nadeau, M. Sundra, and G. S. Makowski
Effect of Protein on Hemoglobin and Hematocrit Assays with a Conductivity-Based Point-of-Care Testing Device: Comparison with Optical Methods
Ann. Clin. Lab. Sci., January 1, 2004; 34(1): 75 - 82.
[Abstract] [Full Text] [PDF]

Home page
 Anesth. Analg.Home page
J. T. Lutz, C. Valentin-Gamazo, K. Gorlinger, M. Malago, and J. Peters
Blood-Transfusion Requirements and Blood Salvage in Donors Undergoing Right Hepatectomy for Living Related Liver Transplantation
Anesth. Analg., February 1, 2003; 96(2): 351 - 355.
[Abstract] [Full Text] [PDF]

Home page
 TraumaHome page
G. Nicol, E. Hunt, and M. Manji
When to give blood
Trauma, October 1, 2001; 3(4): 221 - 233.
[Abstract] [PDF]

Home page
 J. Thorac. Cardiovasc. Surg.Home page
L. YazicioGlu, S. Eryilmaz, M. Sirlak, M. B. Inan, A. Aral, R. Tasoz, N. T. Eren, B. Kaya, and H. Akalin
Recombinant human erythropoietin administration in cardiac surgery
J. Thorac. Cardiovasc. Surg., October 1, 2001; 122(4): 741 - 745.
[Abstract] [Full Text] [PDF]

Home page
 Eur. J. Cardiothorac. Surg.Home page
D. Dougenis, V. Patrinou, K.S. Filos, E. Theodori, K. Vagianos, and A. Maniati
Blood use in lung resection for carcinoma: perioperative elective anaemia does not compromise the early outcome
Eur. J. Cardiothorac. Surg., August 1, 2000; 20(2): 372 - 377.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1999 by the American College of Chest Physicians.